04.11.2014 • NewsBotoxAllerganhostile takeover bid

Allergan Said to Have Received Bid from Actavis

Botox maker Allergan, which is fighting a hostile takeover bid by Valeant Pharmaceutical, is said to have been approached about a potential transaction by another party.

The news agency Reuters quoted sources as saying the bidder is UK drugmaker Actavis.

Valeant and Pershing Square Capital Management, the investment vehicle of activist investor Bill Ackman, own nearly 10% stake of Allergan and have offered $55 billion to take control of the company.

Allergan is trying to convince investors that Valeant's plan for cost-cutting is too extreme.

Reuters reported in early October that Actavis, which had already reached out to Allergan once in the prior months, was planning a second approach to the company with an offer worth more than $200 per share.

Valeant, whose cash-and-stock offer is worth about $182 per share, recently said it was prepared to raise its offer so that it also would be worth around $200 per share.

Bill Ackman and Pershing Square have forced a special meeting of Allergan shareholders, now scheduled for Dec. 18.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.